U.S. market Closed. Opens in 16 hours 52 minutes

CMMB | Chemomab Therapeutics Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue66.83K57.77K34.02K80.00K281.91KN/A
Gross Profit-66.83K-57.77K-34.02K-80.00K-281.91KN/A
Operating Expenses25.33M28.53M12.37M5.97M19.33M13.04M
Selling, General & Admin7.06M11.56M6.03M1.29M5.98M5.49M
Research & Development18.27M16.98M6.33M4.68M13.35M7.56M
Other Operating ExpensesN/AN/AN/A749.00K3.35MN/A
Operating Income-25.39M-28.53M-12.40M-5.97M-19.61M12.66M
Other Expenses / Income1.23M353.00K-77.00K21.00K-7.60MN/A
Before Tax Income-24.16M-28.18M-12.48M-5.95M-27.21M12.66M
Income Tax Expenses-1.00-534.00K77.00K-21.00K1.00-621.00K
Net Income-24.16M-27.65M-12.55M-5.93M-27.21M13.28M
Interest ExpensesN/A353.00K111.08K6.00K9.00KN/A
Basic Shares Outstanding11.75M11.38M10.37M1.85M1.72MN/A
Diluted Shares Outstanding11.75M11.38M10.37M1.85M1.72MN/A
EBITDA-25.33M-28.48M-12.37M-5.95M-19.33M12.66M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-24.16M-27.83M-12.37M-5.95M-27.20M12.66M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙